Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Symptom overlap in anxiety and multiple sclerosis.
Rehabilitation in transverse myelitis.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
Ampyra 10mg beats 5mg, but weak overall results net neutral for ACOR
New data at AAN to confirm efficacy of Novartis' Gilenya® across four key measures of MS disease activity, including brain volume loss
[Immunodepressive therapy in neurology].
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)
Regression-Based Norms Improve the Sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
Recommendations for diagnosis and management of multiple sclerosis.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
Substance Name: Dronabinol
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.

Pages